title: Subcutaneous bortezomib for treatment of TEMPI syndrome.
authors.affiliation: Department of Medicine, Saint Louis University, St. Louis, MO.
authors.forename: Sina
authors.initials: S
authors.lastname: Jasim
authors.affiliation: Division of Hematology-Oncology, Saint Louis University, St. Louis, MO.
authors.forename: Gibran
authors.initials: G
authors.lastname: Mahmud
authors.affiliation: Division of Nephrology, Saint Louis University, St. Louis, MO. Electronic address: bastanib@slu.edu.
authors.forename: Bahar
authors.initials: B
authors.lastname: Bastani
authors.affiliation: Division of Hematology-Oncology, Saint Louis University, St. Louis, MO.
authors.forename: Mark
authors.initials: M
authors.lastname: Fesler
mesh_terms: D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D004487:Edema / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010265:Paraproteinemias / Q000175:diagnosis / Q000188:drug therapy*; D011086:Polycythemia / Q000175:diagnosis / Q000188:drug therapy*; D061988:Proteasome Inhibitors / Q000008:administration & dosage*; D011719:Pyrazines / Q000008:administration & dosage*; D012867:Skin / Q000473:pathology; D013684:Telangiectasis / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D001897:Boronic Acids; D061988:Proteasome Inhibitors; D011719:Pyrazines; D000069286:Bortezomib
keywords: Monoclonal gammopathy; Neuropathy; Perinephric cysts; Polycythemia; Telangiectasia